The Latest
Filter by Topic
Filter by Type
Is federal marijuana rescheduling good for Big Pharma?
With rescheduling, investors and financial institutions that worried about the stigma surrounding marijuana are taking another look.
News April 30
Cannabis MSO Vireo Growth continues buying spree, acquires Fluent in debt-for-stock deal
Cannabis MSO Vireo Growth is poised to become the third-largest operator in medical-only Florida after its purchase of…
News April 30
How cannabis MSO TerrAscend is responding to federal marijuana rescheduling
TerrAscend will leverage federal rescheduling of medical cannabis to drive growth, shape policy with a focus on compliance…
News April 30
Study: Indiana spends $1.8 billion on illegal cannabis, renewing legalization debate
About 1.3 million residents reported using cannabis in the past year. About one-third are daily or near-daily users.
News April 29
Lawsuit: Missouri’s largest cannabis retail chain runs a price-fixing ‘cartel’
A new lawsuit brought by two Missouri cannabis cultivators accuses the state's largest retail chain of running a…
News April 29
Did President Donald Trump accidentally legalize medical marijuana in South Carolina?
States are reacting to federal marijuana rescheduling mostly cautiously, but the policy could have some unintended consequences in…
News April 28
Florida spars with cannabis MSO Trulieve over alleged pollution at cultivation site
The violations include unpermitted impervious surfaces, standing water in stormwater ponds and erosion caused by prolonged water discharge.
News April 28
Leveling the Legal Playing Field
Defensible cannabis pricing data for litigation - eliminate uncertainty, validate claims, and anchor cases in independent market reality.
Sponsored April 28
Voice of the Plant: Cannabis terpenes lead by the nose to wellness and beauty
Cannabis terpenes led Victorine Deych on a voyage of discovery that culminated in her creating a wellness brand.…
News April 28Featured
Latest Sponsored
